327423004: Ferrocontin Continus 562.5mg m/r tablet (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

466908014 Ferrocontin Continus 562.5mg m/r tablet en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

1191467011 Ferrocontin Continus 562.5mg m/r tablet (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core

466908014 Ferrocontin Continus 562.5mg m/r tablet en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

719555015 Ferrocontin Continus 562.5mg m/r tablet (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1191467011 Ferrocontin Continus 562.5mg m/r tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1191467011 Ferrocontin Continus 562.5mg m/r tablet (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ferrocontin Continus 562.5mg m/r tablet	Is a	Ferrous glycine sulfate 562.5mg m/r tablet	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ferrocontin Continus 562.5mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Trace element supplementation	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ferrocontin Continus 562.5mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Iron (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ferrocontin Continus 562.5mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Ferrous glycine sulfate (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ferrocontin Continus 562.5mg m/r tablet	Is a	Ferrous glycine sulfate 562.5mg m/r tablet	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ferrocontin Continus 562.5mg m/r tablet	Has manufactured dose form	A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)

MOVED TO association reference set